Philip Oettinger is a partner in the life sciences practice at Wilson Sonsini Goodrich & Rosati, where he focuses primarily on medical device, biotechnology, pharmaceutical, diagnostic, and digital health companies. His practice involves assisting private and public companies with corporate governance, initial public offerings, mergers and acquisitions, public company reporting, and private equity and debt financings. He routinely works with incubators on structuring matters and balancing their rights with those of the companies they are forming. Philip serves as co-chair of the Finance Committee and the Compensation Committee.

From 1995 until 2000, Philip was with the Securities and Exchange Commission in Washington, D.C., where he inspected stock exchanges, worked on corporate finance matters, led enforcement investigations, and served as special counsel to Commissioner Laura S. Unger.